The global Contact-lens Induced Infection market was valued at US$ 513 million in 2025 and is anticipated to reach US$ 713 million by 2032, at a CAGR of 4.9% from 2026 to 2032.

Contact-lens Induced Infection Market

Contact lens-induced infection refers to an eye infection caused by the improper use, handling, or care of contact lenses. Bacteria, fungi, or parasites can contaminate the lenses, leading to infections such as keratitis, which affects the cornea. Symptoms may include eye redness, pain, blurred vision, discharge, and sensitivity to light. Risk factors include wearing lenses for extended periods, sleeping in them, or failing to clean and store them properly. Prompt medical treatment is crucial to prevent serious complications, including vision loss.

The North American market for Contact-lens Induced Infection is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Contact-lens Induced Infection is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Contact-lens Induced Infection in Hospitals is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Contact-lens Induced Infection include Alcon, Bausch + Lomb, AbbVie, Novartis International, Pfizer, Merck & Co., Santen Pharmaceutical, Teva Pharmaceutical, Roche Holding, Shionogi, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Contact-lens Induced Infection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Contact-lens Induced Infection. The Contact-lens Induced Infection market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Contact-lens Induced Infection market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Contact-lens Induced Infection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Contact-lens Induced Infection Market Report

Report Metric	Details
Report Name	Contact-lens Induced Infection Market
Accounted market size in 2025	US$ 513 million
Forecasted market size in 2032	US$ 713 million
CAGR	4.9%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Antibiotics Corticosteroids Anti-inflammatory Drugs NSAIDs Other
Segment by Application	Hospitals Ophthalmology Clinics Retail Pharmacy Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Alcon, Bausch + Lomb, AbbVie, Novartis International, Pfizer, Merck & Co., Santen Pharmaceutical, Teva Pharmaceutical, Roche Holding, Shionogi, Kowa Company, Otsuka Pharmaceutical, AstraZeneca, Hikma Pharmaceuticals, Dr. Reddy’s Laboratories
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Contact-lens Induced Infection companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Contact-lens Induced Infection Market growing?

Ans: The Contact-lens Induced Infection Market witnessing a CAGR of 4.9% during the forecast period 2026-2032.

What is the Contact-lens Induced Infection Market size in 2032?

Ans: The Contact-lens Induced Infection Market size in 2032 will be US$ 713 million.

Who are the main players in the Contact-lens Induced Infection Market report?

Ans: The main players in the Contact-lens Induced Infection Market are Alcon, Bausch + Lomb, AbbVie, Novartis International, Pfizer, Merck & Co., Santen Pharmaceutical, Teva Pharmaceutical, Roche Holding, Shionogi, Kowa Company, Otsuka Pharmaceutical, AstraZeneca, Hikma Pharmaceuticals, Dr. Reddy’s Laboratories

What are the Application segmentation covered in the Contact-lens Induced Infection Market report?

Ans: The Applications covered in the Contact-lens Induced Infection Market report are Hospitals, Ophthalmology Clinics, Retail Pharmacy, Other

What are the Type segmentation covered in the Contact-lens Induced Infection Market report?

Ans: The Types covered in the Contact-lens Induced Infection Market report are Antibiotics, Corticosteroids, Anti-inflammatory Drugs, NSAIDs, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Contact-lens Induced Infection Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Antibiotics

1.2.3 Corticosteroids

1.2.4 Anti-inflammatory Drugs

1.2.5 NSAIDs

1.2.6 Other

1.3 Market by Application

1.3.1 Global Contact-lens Induced Infection Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospitals

1.3.3 Ophthalmology Clinics

1.3.4 Retail Pharmacy

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Contact-lens Induced Infection Market Perspective (2021–2032)

2.2 Global Contact-lens Induced Infection Growth Trends by Region

2.2.1 Global Contact-lens Induced Infection Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Contact-lens Induced Infection Historic Market Size by Region (2021–2026)

2.2.3 Contact-lens Induced Infection Forecasted Market Size by Region (2027–2032)

2.3 Contact-lens Induced Infection Market Dynamics

2.3.1 Contact-lens Induced Infection Industry Trends

2.3.2 Contact-lens Induced Infection Market Drivers

2.3.3 Contact-lens Induced Infection Market Challenges

2.3.4 Contact-lens Induced Infection Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Contact-lens Induced Infection Players by Revenue

3.1.1 Global Top Contact-lens Induced Infection Players by Revenue (2021–2026)

3.1.2 Global Contact-lens Induced Infection Revenue Market Share by Players (2021–2026)

3.2 Global Top Contact-lens Induced Infection Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Contact-lens Induced Infection Revenue

3.4 Global Contact-lens Induced Infection Market Concentration Ratio

3.4.1 Global Contact-lens Induced Infection Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Contact-lens Induced Infection Revenue in 2025

3.5 Global Key Players of Contact-lens Induced Infection Head Offices and Areas Served

3.6 Global Key Players of Contact-lens Induced Infection, Products and Applications

3.7 Global Key Players of Contact-lens Induced Infection, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Contact-lens Induced Infection Breakdown Data by Type

4.1 Global Contact-lens Induced Infection Historic Market Size by Type (2021–2026)

4.2 Global Contact-lens Induced Infection Forecasted Market Size by Type (2027–2032)

5 Contact-lens Induced Infection Breakdown Data by Application

5.1 Global Contact-lens Induced Infection Historic Market Size by Application (2021–2026)

5.2 Global Contact-lens Induced Infection Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Contact-lens Induced Infection Market Size (2021–2032)

6.2 North America Contact-lens Induced Infection Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Contact-lens Induced Infection Market Size by Country (2021–2026)

6.4 North America Contact-lens Induced Infection Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Contact-lens Induced Infection Market Size (2021–2032)

7.2 Europe Contact-lens Induced Infection Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Contact-lens Induced Infection Market Size by Country (2021–2026)

7.4 Europe Contact-lens Induced Infection Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Contact-lens Induced Infection Market Size (2021–2032)

8.2 Asia-Pacific Contact-lens Induced Infection Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Contact-lens Induced Infection Market Size by Region (2021–2026)

8.4 Asia-Pacific Contact-lens Induced Infection Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Contact-lens Induced Infection Market Size (2021–2032)

9.2 Latin America Contact-lens Induced Infection Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Contact-lens Induced Infection Market Size by Country (2021–2026)

9.4 Latin America Contact-lens Induced Infection Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Contact-lens Induced Infection Market Size (2021–2032)

10.2 Middle East & Africa Contact-lens Induced Infection Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Contact-lens Induced Infection Market Size by Country (2021–2026)

10.4 Middle East & Africa Contact-lens Induced Infection Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Alcon

11.1.1 Alcon Company Details

11.1.2 Alcon Business Overview

11.1.3 Alcon Contact-lens Induced Infection Introduction

11.1.4 Alcon Revenue in Contact-lens Induced Infection Business (2021–2026)

11.1.5 Alcon Recent Development

11.2 Bausch + Lomb

11.2.1 Bausch + Lomb Company Details

11.2.2 Bausch + Lomb Business Overview

11.2.3 Bausch + Lomb Contact-lens Induced Infection Introduction

11.2.4 Bausch + Lomb Revenue in Contact-lens Induced Infection Business (2021–2026)

11.2.5 Bausch + Lomb Recent Development

11.3 AbbVie

11.3.1 AbbVie Company Details

11.3.2 AbbVie Business Overview

11.3.3 AbbVie Contact-lens Induced Infection Introduction

11.3.4 AbbVie Revenue in Contact-lens Induced Infection Business (2021–2026)

11.3.5 AbbVie Recent Development

11.4 Novartis International

11.4.1 Novartis International Company Details

11.4.2 Novartis International Business Overview

11.4.3 Novartis International Contact-lens Induced Infection Introduction

11.4.4 Novartis International Revenue in Contact-lens Induced Infection Business (2021–2026)

11.4.5 Novartis International Recent Development

11.5 Pfizer

11.5.1 Pfizer Company Details

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Contact-lens Induced Infection Introduction

11.5.4 Pfizer Revenue in Contact-lens Induced Infection Business (2021–2026)

11.5.5 Pfizer Recent Development

11.6 Merck & Co.

11.6.1 Merck & Co. Company Details

11.6.2 Merck & Co. Business Overview

11.6.3 Merck & Co. Contact-lens Induced Infection Introduction

11.6.4 Merck & Co. Revenue in Contact-lens Induced Infection Business (2021–2026)

11.6.5 Merck & Co. Recent Development

11.7 Santen Pharmaceutical

11.7.1 Santen Pharmaceutical Company Details

11.7.2 Santen Pharmaceutical Business Overview

11.7.3 Santen Pharmaceutical Contact-lens Induced Infection Introduction

11.7.4 Santen Pharmaceutical Revenue in Contact-lens Induced Infection Business (2021–2026)

11.7.5 Santen Pharmaceutical Recent Development

11.8 Teva Pharmaceutical

11.8.1 Teva Pharmaceutical Company Details

11.8.2 Teva Pharmaceutical Business Overview

11.8.3 Teva Pharmaceutical Contact-lens Induced Infection Introduction

11.8.4 Teva Pharmaceutical Revenue in Contact-lens Induced Infection Business (2021–2026)

11.8.5 Teva Pharmaceutical Recent Development

11.9 Roche Holding

11.9.1 Roche Holding Company Details

11.9.2 Roche Holding Business Overview

11.9.3 Roche Holding Contact-lens Induced Infection Introduction

11.9.4 Roche Holding Revenue in Contact-lens Induced Infection Business (2021–2026)

11.9.5 Roche Holding Recent Development

11.10 Shionogi

11.10.1 Shionogi Company Details

11.10.2 Shionogi Business Overview

11.10.3 Shionogi Contact-lens Induced Infection Introduction

11.10.4 Shionogi Revenue in Contact-lens Induced Infection Business (2021–2026)

11.10.5 Shionogi Recent Development

11.11 Kowa Company

11.11.1 Kowa Company Company Details

11.11.2 Kowa Company Business Overview

11.11.3 Kowa Company Contact-lens Induced Infection Introduction

11.11.4 Kowa Company Revenue in Contact-lens Induced Infection Business (2021–2026)

11.11.5 Kowa Company Recent Development

11.12 Otsuka Pharmaceutical

11.12.1 Otsuka Pharmaceutical Company Details

11.12.2 Otsuka Pharmaceutical Business Overview

11.12.3 Otsuka Pharmaceutical Contact-lens Induced Infection Introduction

11.12.4 Otsuka Pharmaceutical Revenue in Contact-lens Induced Infection Business (2021–2026)

11.12.5 Otsuka Pharmaceutical Recent Development

11.13 AstraZeneca

11.13.1 AstraZeneca Company Details

11.13.2 AstraZeneca Business Overview

11.13.3 AstraZeneca Contact-lens Induced Infection Introduction

11.13.4 AstraZeneca Revenue in Contact-lens Induced Infection Business (2021–2026)

11.13.5 AstraZeneca Recent Development

11.14 Hikma Pharmaceuticals

11.14.1 Hikma Pharmaceuticals Company Details

11.14.2 Hikma Pharmaceuticals Business Overview

11.14.3 Hikma Pharmaceuticals Contact-lens Induced Infection Introduction

11.14.4 Hikma Pharmaceuticals Revenue in Contact-lens Induced Infection Business (2021–2026)

11.14.5 Hikma Pharmaceuticals Recent Development

11.15 Dr. Reddy’s Laboratories

11.15.1 Dr. Reddy’s Laboratories Company Details

11.15.2 Dr. Reddy’s Laboratories Business Overview

11.15.3 Dr. Reddy’s Laboratories Contact-lens Induced Infection Introduction

11.15.4 Dr. Reddy’s Laboratories Revenue in Contact-lens Induced Infection Business (2021–2026)

11.15.5 Dr. Reddy’s Laboratories Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Alcon

Bausch & Lomb

AbbVie

Novartis International

Pfizer Inc

Merck

Santen Pharmaceutical

Otsuka Pharmaceutical

Astrazeneca plc

Hikma Pharmaceuticals

Dr. Reddy’s Laboratories

List of Tables

Table 1. Global Contact-lens Induced Infection Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Antibiotics

Table 3. Key Players of Corticosteroids

Table 4. Key Players of Anti-inflammatory Drugs

Table 5. Key Players of NSAIDs

Table 6. Key Players of Other

Table 7. Global Contact-lens Induced Infection Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Contact-lens Induced Infection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 9. Global Contact-lens Induced Infection Market Size by Region (US$ Million), 2021–2026

Table 10. Global Contact-lens Induced Infection Market Share by Region (2021–2026)

Table 11. Global Contact-lens Induced Infection Forecasted Market Size by Region (US$ Million), 2027–2032

Table 12. Global Contact-lens Induced Infection Market Share by Region (2027–2032)

Table 13. Contact-lens Induced Infection Market Trends

Table 14. Contact-lens Induced Infection Market Drivers

Table 15. Contact-lens Induced Infection Market Challenges

Table 16. Contact-lens Induced Infection Market Restraints

Table 17. Global Contact-lens Induced Infection Revenue by Players (US$ Million), 2021–2026

Table 18. Global Contact-lens Induced Infection Market Share by Players (2021–2026)

Table 19. Global Top Contact-lens Induced Infection Players by Tier (Tier 1, Tier 2, and Tier 3), based on Contact-lens Induced Infection Revenue, 2025

Table 20. Ranking of Global Top Contact-lens Induced Infection Companies by Revenue (US$ Million) in 2025

Table 21. Global 5 Largest Players Market Share by Contact-lens Induced Infection Revenue (CR5 and HHI), 2021–2026

Table 22. Global Key Players of Contact-lens Induced Infection, Headquarters and Area Served

Table 23. Global Key Players of Contact-lens Induced Infection, Products and Applications

Table 24. Global Key Players of Contact-lens Induced Infection, Date of General Availability (GA)

Table 25. Mergers and Acquisitions, Expansion Plans

Table 26. Global Contact-lens Induced Infection Market Size by Type (US$ Million), 2021–2026

Table 27. Global Contact-lens Induced Infection Revenue Market Share by Type (2021–2026)

Table 28. Global Contact-lens Induced Infection Forecasted Market Size by Type (US$ Million), 2027–2032

Table 29. Global Contact-lens Induced Infection Revenue Market Share by Type (2027–2032)

Table 30. Global Contact-lens Induced Infection Market Size by Application (US$ Million), 2021–2026

Table 31. Global Contact-lens Induced Infection Revenue Market Share by Application (2021–2026)

Table 32. Global Contact-lens Induced Infection Forecasted Market Size by Application (US$ Million), 2027–2032

Table 33. Global Contact-lens Induced Infection Revenue Market Share by Application (2027–2032)

Table 34. North America Contact-lens Induced Infection Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. North America Contact-lens Induced Infection Market Size by Country (US$ Million), 2021–2026

Table 36. North America Contact-lens Induced Infection Market Size by Country (US$ Million), 2027–2032

Table 37. Europe Contact-lens Induced Infection Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 38. Europe Contact-lens Induced Infection Market Size by Country (US$ Million), 2021–2026

Table 39. Europe Contact-lens Induced Infection Market Size by Country (US$ Million), 2027–2032

Table 40. Asia-Pacific Contact-lens Induced Infection Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 41. Asia-Pacific Contact-lens Induced Infection Market Size by Region (US$ Million), 2021–2026

Table 42. Asia-Pacific Contact-lens Induced Infection Market Size by Region (US$ Million), 2027–2032

Table 43. Latin America Contact-lens Induced Infection Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Latin America Contact-lens Induced Infection Market Size by Country (US$ Million), 2021–2026

Table 45. Latin America Contact-lens Induced Infection Market Size by Country (US$ Million), 2027–2032

Table 46. Middle East & Africa Contact-lens Induced Infection Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 47. Middle East & Africa Contact-lens Induced Infection Market Size by Country (US$ Million), 2021–2026

Table 48. Middle East & Africa Contact-lens Induced Infection Market Size by Country (US$ Million), 2027–2032

Table 49. Alcon Company Details

Table 50. Alcon Business Overview

Table 51. Alcon Contact-lens Induced Infection Product

Table 52. Alcon Revenue in Contact-lens Induced Infection Business (US$ Million), 2021–2026

Table 53. Alcon Recent Development

Table 54. Bausch + Lomb Company Details

Table 55. Bausch + Lomb Business Overview

Table 56. Bausch + Lomb Contact-lens Induced Infection Product

Table 57. Bausch + Lomb Revenue in Contact-lens Induced Infection Business (US$ Million), 2021–2026

Table 58. Bausch + Lomb Recent Development

Table 59. AbbVie Company Details

Table 60. AbbVie Business Overview

Table 61. AbbVie Contact-lens Induced Infection Product

Table 62. AbbVie Revenue in Contact-lens Induced Infection Business (US$ Million), 2021–2026

Table 63. AbbVie Recent Development

Table 64. Novartis International Company Details

Table 65. Novartis International Business Overview

Table 66. Novartis International Contact-lens Induced Infection Product

Table 67. Novartis International Revenue in Contact-lens Induced Infection Business (US$ Million), 2021–2026

Table 68. Novartis International Recent Development

Table 69. Pfizer Company Details

Table 70. Pfizer Business Overview

Table 71. Pfizer Contact-lens Induced Infection Product

Table 72. Pfizer Revenue in Contact-lens Induced Infection Business (US$ Million), 2021–2026

Table 73. Pfizer Recent Development

Table 74. Merck & Co. Company Details

Table 75. Merck & Co. Business Overview

Table 76. Merck & Co. Contact-lens Induced Infection Product

Table 77. Merck & Co. Revenue in Contact-lens Induced Infection Business (US$ Million), 2021–2026

Table 78. Merck & Co. Recent Development

Table 79. Santen Pharmaceutical Company Details

Table 80. Santen Pharmaceutical Business Overview

Table 81. Santen Pharmaceutical Contact-lens Induced Infection Product

Table 82. Santen Pharmaceutical Revenue in Contact-lens Induced Infection Business (US$ Million), 2021–2026

Table 83. Santen Pharmaceutical Recent Development

Table 84. Teva Pharmaceutical Company Details

Table 85. Teva Pharmaceutical Business Overview

Table 86. Teva Pharmaceutical Contact-lens Induced Infection Product

Table 87. Teva Pharmaceutical Revenue in Contact-lens Induced Infection Business (US$ Million), 2021–2026

Table 88. Teva Pharmaceutical Recent Development

Table 89. Roche Holding Company Details

Table 90. Roche Holding Business Overview

Table 91. Roche Holding Contact-lens Induced Infection Product

Table 92. Roche Holding Revenue in Contact-lens Induced Infection Business (US$ Million), 2021–2026

Table 93. Roche Holding Recent Development

Table 94. Shionogi Company Details

Table 95. Shionogi Business Overview

Table 96. Shionogi Contact-lens Induced Infection Product

Table 97. Shionogi Revenue in Contact-lens Induced Infection Business (US$ Million), 2021–2026

Table 98. Shionogi Recent Development

Table 99. Kowa Company Company Details

Table 100. Kowa Company Business Overview

Table 101. Kowa Company Contact-lens Induced Infection Product

Table 102. Kowa Company Revenue in Contact-lens Induced Infection Business (US$ Million), 2021–2026

Table 103. Kowa Company Recent Development

Table 104. Otsuka Pharmaceutical Company Details

Table 105. Otsuka Pharmaceutical Business Overview

Table 106. Otsuka Pharmaceutical Contact-lens Induced Infection Product

Table 107. Otsuka Pharmaceutical Revenue in Contact-lens Induced Infection Business (US$ Million), 2021–2026

Table 108. Otsuka Pharmaceutical Recent Development

Table 109. AstraZeneca Company Details

Table 110. AstraZeneca Business Overview

Table 111. AstraZeneca Contact-lens Induced Infection Product

Table 112. AstraZeneca Revenue in Contact-lens Induced Infection Business (US$ Million), 2021–2026

Table 113. AstraZeneca Recent Development

Table 114. Hikma Pharmaceuticals Company Details

Table 115. Hikma Pharmaceuticals Business Overview

Table 116. Hikma Pharmaceuticals Contact-lens Induced Infection Product

Table 117. Hikma Pharmaceuticals Revenue in Contact-lens Induced Infection Business (US$ Million), 2021–2026

Table 118. Hikma Pharmaceuticals Recent Development

Table 119. Dr. Reddy’s Laboratories Company Details

Table 120. Dr. Reddy’s Laboratories Business Overview

Table 121. Dr. Reddy’s Laboratories Contact-lens Induced Infection Product

Table 122. Dr. Reddy’s Laboratories Revenue in Contact-lens Induced Infection Business (US$ Million), 2021–2026

Table 123. Dr. Reddy’s Laboratories Recent Development

Table 124. Research Programs/Design for This Report

Table 125. Key Data Information from Secondary Sources

Table 126. Key Data Information from Primary Sources

Table 127. Authors List of This Report

List of Figures

Figure 1. Contact-lens Induced Infection Picture

Figure 2. Global Contact-lens Induced Infection Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Contact-lens Induced Infection Market Share by Type: 2025 vs 2032

Figure 4. Antibiotics Features

Figure 5. Corticosteroids Features

Figure 6. Anti-inflammatory Drugs Features

Figure 7. NSAIDs Features

Figure 8. Other Features

Figure 9. Global Contact-lens Induced Infection Market Size by Application (US$ Million), 2021–2032

Figure 10. Global Contact-lens Induced Infection Market Share by Application: 2025 vs 2032

Figure 11. Hospitals Case Studies

Figure 12. Ophthalmology Clinics Case Studies

Figure 13. Retail Pharmacy Case Studies

Figure 14. Other Case Studies

Figure 15. Contact-lens Induced Infection Report Years Considered

Figure 16. Global Contact-lens Induced Infection Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 17. Global Contact-lens Induced Infection Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 18. Global Contact-lens Induced Infection Market Share by Region: 2025 vs 2032

Figure 19. Global Contact-lens Induced Infection Market Share by Players in 2025

Figure 20. Global Contact-lens Induced Infection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 21. The Top 10 and 5 Players Market Share by Contact-lens Induced Infection Revenue in 2025

Figure 22. North America Contact-lens Induced Infection Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. North America Contact-lens Induced Infection Market Share by Country (2021–2032)

Figure 24. United States Contact-lens Induced Infection Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Canada Contact-lens Induced Infection Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Europe Contact-lens Induced Infection Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Europe Contact-lens Induced Infection Market Share by Country (2021–2032)

Figure 28. Germany Contact-lens Induced Infection Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. France Contact-lens Induced Infection Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. U.K. Contact-lens Induced Infection Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Italy Contact-lens Induced Infection Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Russia Contact-lens Induced Infection Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Ireland Contact-lens Induced Infection Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Asia-Pacific Contact-lens Induced Infection Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Asia-Pacific Contact-lens Induced Infection Market Share by Region (2021–2032)

Figure 36. China Contact-lens Induced Infection Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Japan Contact-lens Induced Infection Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. South Korea Contact-lens Induced Infection Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Southeast Asia Contact-lens Induced Infection Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. India Contact-lens Induced Infection Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Australia & New Zealand Contact-lens Induced Infection Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Latin America Contact-lens Induced Infection Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Latin America Contact-lens Induced Infection Market Share by Country (2021–2032)

Figure 44. Mexico Contact-lens Induced Infection Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Brazil Contact-lens Induced Infection Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Middle East & Africa Contact-lens Induced Infection Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Middle East & Africa Contact-lens Induced Infection Market Share by Country (2021–2032)

Figure 48. Israel Contact-lens Induced Infection Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Saudi Arabia Contact-lens Induced Infection Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. UAE Contact-lens Induced Infection Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Alcon Revenue Growth Rate in Contact-lens Induced Infection Business (2021–2026)

Figure 52. Bausch + Lomb Revenue Growth Rate in Contact-lens Induced Infection Business (2021–2026)

Figure 53. AbbVie Revenue Growth Rate in Contact-lens Induced Infection Business (2021–2026)

Figure 54. Novartis International Revenue Growth Rate in Contact-lens Induced Infection Business (2021–2026)

Figure 55. Pfizer Revenue Growth Rate in Contact-lens Induced Infection Business (2021–2026)

Figure 56. Merck & Co. Revenue Growth Rate in Contact-lens Induced Infection Business (2021–2026)

Figure 57. Santen Pharmaceutical Revenue Growth Rate in Contact-lens Induced Infection Business (2021–2026)

Figure 58. Teva Pharmaceutical Revenue Growth Rate in Contact-lens Induced Infection Business (2021–2026)

Figure 59. Roche Holding Revenue Growth Rate in Contact-lens Induced Infection Business (2021–2026)

Figure 60. Shionogi Revenue Growth Rate in Contact-lens Induced Infection Business (2021–2026)

Figure 61. Kowa Company Revenue Growth Rate in Contact-lens Induced Infection Business (2021–2026)

Figure 62. Otsuka Pharmaceutical Revenue Growth Rate in Contact-lens Induced Infection Business (2021–2026)

Figure 63. AstraZeneca Revenue Growth Rate in Contact-lens Induced Infection Business (2021–2026)

Figure 64. Hikma Pharmaceuticals Revenue Growth Rate in Contact-lens Induced Infection Business (2021–2026)

Figure 65. Dr. Reddy’s Laboratories Revenue Growth Rate in Contact-lens Induced Infection Business (2021–2026)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions